43 reports

  • 4.1 ETIOLOGY
  • 12.1 BIBLIOGRAPHY

TUBERCULOSIS AND HIV.

  • Antiviral
  • East Asia
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • ViiV Healthcare Ltd.
  • Chapter V
  • Chapter V

IN 2007, THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA AWARDED CHINA A FIVE-YEAR GRANT TO STRENGTHEN THE OPERATIONAL SYSTEM OF THE FREE ANTIRETROVIRAL TREATMENT PROGRAMME.

  • Antiviral
  • China
  • Demand
  • Market Size
  • Supply

Tuberculosis and HIV.

  • Antiviral
  • East Asia
  • Japan
  • Forecast
  • UNAIDS

STRENGTH: ## LOW; ## HIGH F.

  • Antiviral
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • ViiV Healthcare Ltd.

Source: GlobalData, Pharma Intelligence Center [Accessed February 2018] Pre-Registration ## ## - - ## - Filing rejected/ Withdrawn ## - - ## - - Phase III ## ## - - ## ## Phase II ## - - - ## ## Phase I ## - ## - ## ## Phase ## - - - - - ## IND/ CTA Fil

  • Antiviral
  • United States
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • ViiV Healthcare Ltd.

Periodic Assessment of the Molecular Diagnostic Market for Mycobacterium tuberculosis (MTB) Tests in Italy, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small,

  • Antiviral
  • Infectious Disease
  • Molecular Diagnostic
  • Pathology
  • Italy

Periodic Assessment of the Molecular Diagnostic Market for Mycobacterium tuberculosis (MTB) Tests in Germany, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: smal

  • Antiviral
  • Infectious Disease
  • Molecular Diagnostic
  • Pathology
  • Germany

Periodic Assessment of the Molecular Diagnostic Market for Mycobacterium tuberculosis (MTB) Tests in UK, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, me

  • Antiviral
  • Infectious Disease
  • Molecular Diagnostic
  • Pathology
  • United Kingdom

Periodic Assessment of the Molecular Diagnostic Market for Mycobacterium tuberculosis (MTB) Tests in France, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small

  • Antiviral
  • Infectious Disease
  • Molecular Diagnostic
  • Pathology
  • France

Periodic Assessment of the Molecular Diagnostic Market for Mycobacterium tuberculosis (MTB) Tests in Switzerland, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment:

  • Antiviral
  • Infectious Disease
  • Molecular Diagnostic
  • Pathology
  • Switzerland

Periodic Assessment of the Molecular Diagnostic Market for Mycobacterium tuberculosis (MTB) Tests in Sweden, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small

  • Antiviral
  • Infectious Disease
  • Molecular Diagnostic
  • Pathology
  • Sweden

Periodic Assessment of the Molecular Diagnostic Market for Mycobacterium tuberculosis (MTB) Tests in Spain, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small,

  • Antiviral
  • Infectious Disease
  • Molecular Diagnostic
  • Pathology
  • Spain

Periodic Assessment of the Molecular Diagnostic Market for Mycobacterium tuberculosis (MTB) Tests in The Netherlands, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segme

  • Antiviral
  • Infectious Disease
  • Molecular Diagnostic
  • Pathology
  • Netherlands
  • RENAME

These include malaria, tuberculosis, cholera, meningitis and a number of sexually-transmitted infections.

  • Antiviral
  • Pharmaceutical
  • Brazil
  • Demand
  • GlaxoSmithKline plc

HIV

4546 5000 3864

Kim AY, Chung RT (2009) Coinfection With HIV-## and HCV-A One-Two Punch.

  • Antiviral
  • Europe
  • European Union
  • North America
  • United States

THE APPROACH OF USING COMBINATION THERAPY WAS INITIALLY ADOPTED TO TREAT TUBERCULOSIS AND OTHER INFECTIOUS DISEASES.

  • Antiviral
  • North America
  • United States
  • Incyte Corporation
  • Merck & Co., Inc.
  • CC-11050 - DRUG PROFILE

" We think we can do it with one shot. "

  • Antiviral
  • Infectious Disease
  • United States
  • World
  • Product Initiative
  • SMALL MOLECULES FOR TUBERCULOSIS - DRUG PROFILE
  • SMALL MOLECULES 4 FOR ONCOLOGY - DRUG PROFILE

Biomar Microbial Technologies - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Biomar Microbial Technologies - Product Pipeline Review - 2016’, provides an overview of the Biomar Microbial Technologies’s pharmaceutical research and development focus. The report provides comprehensive information...

  • Antiviral
  • Oncology
  • Therapy
  • World
  • Product Initiative

## Infection ## Vitamin B## Deficiency ## Human Immunodeficiency Virus Type ## Infection ## Cytomegalovirus Infection ## Hepatitis A Infection ## Hepatitis C Infection ## Kidney Disease ## Metastatic Melanoma ## Lung Cancer ## Mycobacterium avium ## Tuberculosis ## Preeclampsia ## Thyroid Cancer

  • Anesthetics
  • Antiviral
  • Targeted Therapy
  • Transplantation
  • Roche Group
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Bristol-Myers Squibb Company ## ## ## ## ## ## ## ## Merck & Co Inc ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Bukwang Pharm Co Ltd ## ## ## ## ## ##

  • Antiviral
  • Hepatitis
  • Infectious Disease
  • World
  • GlaxoSmithKline plc
  • CHIMERIX ENTERS INTO LICENSING AGREEMENT WITH CONTRAVIR PHARMA FOR CMX157

It also develops active compounds against influenza A and B, malaria, brincidofovir for smallpox, brincidofovir and adenovirus, dengue virus and tuberculosis.

  • Antiviral
  • Hepatitis
  • United States
  • Corporate Finance
  • ContraVir Pharmaceuticals, Inc.

Tamiflu (oseltamivir) and Alferon were tested in A## cells for antiviral activity in vitro against the wild-type (wt) human A(H##N##) isolate A/ Anhui/ ##/ 2013 (wt Anhui ##) and a patient isolate (A/ Shanghai/ ##/ 2013 (NA-##K; Shanghai ##- NA

  • Antiviral
  • United States
  • World
  • Product Initiative
  • Hemispherx Biopharma, Inc.

The institute' s research areas include infectious diseases such as tuberculosis and influenza, HIV/ AIDS, biodefense; and immune-mediated diseases including asthma and allergy.

  • Antiviral
  • Healthcare
  • Israel
  • United States
  • BiondVax Pharmaceuticals Ltd.
  • Discovery/Preclinical Trial Details
  • LALISTAT - DRUG PROFILE

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2017, provides an overview of the Human Immunodeficiency...

  • Antiviral
  • HIV AIDS
  • Pathology
  • Vaccine
  • Merck & Co., Inc.

One unit refers to one test kit.

  • Antiviral
  • Clinical Trial
  • Hepatitis
  • RNA
  • Abbott

The period saw the launch of the Genedrive®tuberculosis (TB) and associated antibiotic resistance test in India.

  • Antiviral
  • Clinical Trial
  • DNA
  • Hepatitis
  • GlobalData's company

The company' s products find applications in the treatment of diseases such as AIDS, malaria and tuberculosis.

  • Antiviral
  • Therapy
  • India
  • M&A
  • Cipla Ltd
  • SMALLPOX - PIPELINE BY CHIMERIX INC, H1 2018
  • SMALLPOX - PIPELINE BY CEL-SCI CORP, H1 2018

It also develops active compounds against influenza A and B, malaria, brincidofovir for smallpox, brincidofovir and adenovirus, dengue virus and tuberculosis.

  • Antiviral
  • Therapy
  • United States
  • Product Initiative
  • Chimerix, Inc.

It is currently in Phase ## clinical development.

  • Antiviral
  • United States
  • World
  • Forecast
  • Gilead Sciences, Inc.

The company also develops recombinant proteins, diagnostic products, artificial immunogens and antibody technologies, and tuberculosis vaccine.

  • Antiviral
  • Pharmaceutical
  • Belgium
  • World
  • Deals & Alliance